MUC2 gene suppression in human colorectal carcinomas and their metastases: In vitro evidence of the modulatory role of DNA methylation

Laboratory Investigation

Volumn 77, Issue 6, 1997, Pages 685-695

  Hanski, Christoph ^a   Riede, Eva ^a   Gratchev, Alexei ^a   Foss, Hans Dieter ^a   Böhm, Christian ^a   Klußmann, Enno ^a   Hummel, Michael ^a   Mann, Benno ^a   Buhr, Heinz Johannes ^a   Stein, Harald ^a   Kim, Young S ^b   Gum, Jim ^b   Riecken, Ernst Otto ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER METASTASIS; LYMPH NODE METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BASE SEQUENCE; CARCINOMA; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; HUMANS; MOLECULAR SEQUENCE DATA; MUCINS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031474251     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ahuja N, Mohan A, Li Q, Stoiker J, Hamilton S, Baylin SB, and Issa JPJ (1997). Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 57:3370-3374.
2. Baeckstrom D and Hansson GC (1996). The transcripts of the apomucin genes MUC2, MUC4, and MUC5AC are large and appear as distinct bands. Glycoconj J 13:833-837.
3. Blank M, Klussmann E, Krüger-Krasagakes S, Schmitt-Gräff A, Stolte M, Bornhoeft G, Stein H, Xing PX, McKenzie IFC, Verstijnen CPHJ, Riecken EO, and Hanski C (1994). Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 59:301-306.
4. Bodmer WF, Browning MJ, Krausa P, Rowan A, Bicknell DC, and Bodmer JG (1993). Tumor escape from immune response by variation in HLA expression and other mechanisms. Ann NY Acad Sci 690:42-49.
5. Bresalier RS, Niv Y, Byrd JC, Duh Q, Toribara NW, Rockwell RW, Dahiya R, and Kim YS (1991). Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87:1037-1045.
6. Carrato C, Balague C, de Bolos C, Gonzalez E, Gambus G, Planas J, Perini JM, Andreu D, and Real FX (1994). Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology 107:160-172.
7. Chang SK, Dohrmann AF, Basbaum CB, Ho SB, Tsuda T, Toribara NW, Gum JR, and Kim YS (1994). Localisation of mucin (MUC2 and MUC3) mRNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107:28-36.
8. Counts JL and Goodman JI (1995). Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83:13-15.
9. de Bustros A, Nelkin BD, Silverman AL, Ehrlich G, Poiesz B, and Baylin SB (1988). The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A 85:5693-5697.
10. Feinberg AP, Gehrke CW, Kuo KC, and Ehrlich G (1988). Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48:1159-1161.
11. Feinberg AP, Rainier S, and DeBaun MR (1995). Genomic imprinting, DNA methylation, and cancer. J Natl Cancer Inst Monogr 17:21-26.
12. Goelz SE, Vogelstein B, Hamilton SR, and Feinberg AP (1985). Hypomethylation of DNA from benign and malignant colon neoplasms. Science 228:187-190.
13. Gum JR, Byrd JC, Hicks JW, Toribara NW, Lamport DTA, and Kim YS (1989). Molecular cloning of human intestinal mucus cDNAs: Sequence analysis and evidence for genetic polymorphism. J Biol Chem 264:6480-6487.
14. Gum JR, Hicks JW and Kim YS (1997). Identification and characterization of the MUC2 (human intestianl mucin) gene 5′-flanking region: Promoter activity in cultured cells. Biochem J 325:259-267.
15. Gum JR, Hicks JW, Toribara NW, Siddiki B, and Kim YS (1994). Molecular cloning of human intestinal mucin (MUC2) cDNA. J Biol Chem 269:2440-2446.
16. Hanski C, Bornhoeft G, Topf N, Hermann U, Stein H, and Riecken EO (1990). Detection of a mucin marker for the adenoma-carcinoma sequence in human colonic mucosa by monoclonal antibody AM-3. J Clin Pathol 43:379-385.
17. x-positive mucins present in colon, colon carcinoma and sera of patients with colorectal cancer. Cancer Res 55:928-933.
18. x expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue. Glycoconj J 13:1-7.
19. x moiety is an independent and a more consistent marker of colon carcinogenesis than the overexpression of c-myc and Ki-ras oncogenes. Int J Oncol 4:993-1000.
20. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D, and Baylin SB (1995). Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant methylation in all common human cancers. Cancer Res 55:4525-4530.
21. Hermanek P, Gospodarowicz MK, Hensen DE, Hutter RVP, and Sobin LH, editors (1995). Prognostic factors in cancer. Berlin: UICC, Springer Verlag.
22. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, and Kim YS (1993). Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53:641-651.
23. Israel DI (1993). A PCR-based method for high stringency screening of DNA libraries. Nucleic Acids Res 21:2627-2631.
24. Issa JPJ, Vertino PM, Wu J, Sazawal S, Celano P, Nelkin BD, Hamilton SR, and Baylin SB (1993). Increased cytosine DNA-methyltransferase activity during colon cancer progression. J Natl Cancer Inst 85:1235-1240.
25. Jones PA (1985). Altering gene expreession with 5-azacytidine. Cell 40:485-486.
26. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, and Jaenisch R (1995). Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205.
27. Lengauer C, Kinzler KW, and Vogelstein B (1997). DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A 94:2545-2550.
28. Lesuffleur T, Zweibaum A, and Real FX (1994). Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol 17:153-180.
29. Moll R, Franke WW, Schiller DL, Geiger B, and Krepler R (1982). The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
30. Ogata S, Uehara H, Chen A, and Itzkowitz SH (1992). Mucin gene expression in colonic tissues and cell lines. Cancer Res 52:5971-5978.
31. x. Science 250:1130-1132.
32. Sambrook J, Fritsch EF, and Maniatis T (1989). Molecular cloning: A laboratory manual. Cold Spring Harbor: Laboratory Press.
33. Sharard RM, Royds JA, Rogers S, and Shorthause AJ (1992). Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 65:667-672.
34. Silverman AL, Park JG, Hamilton SR, Gazdar AF, Luk GD, and Baylin SB (1989). Abnormal methylation of the calcitonin gene in human colonic neoplasia. Cancer Res 49:3468-3473.
35. Verstijnen CPHJ, Arends JW, Moerkerk PTM, Geraedts JPM, Sekikawa KS, Uitendaal MP, and Bosman FT (1987). The establishment and characterization of two new cell lines derived from a single human colonic adenocarcinoma. Virchows Arch B 53:191-197.
36. x determinant on myeloid and tumor cells. Science 250:1132-1135.
37. Weiss AA, Babyatsky MW, Ogata S, Chen A, and Itzkowitz SH (1996). Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem 44:1161-1166.
38. Wu CS, Tung SY, Chen PC, and Kuo YC (1996). Clinicopathological study of colorectal carcinomas in Taiwan: A multi-variate analysis. J Gastroenterol Hepatol 11:77-81.
39. Xing PX, Prenzoska J, Layton GT, Devine PL, and McKenzie IFC (1992). Second generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst 84:699-703.
40. Yonezwa S, Sueyoshi K, Nomoto M, Kitamura H, Nagata K, Arimura Y, Tanaka S, Hollingsworth MA, Siddiki B, Kim YS, and Sato E (1997). MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients. Hum Path 28:344-352.
41. Yoo S, Ho I, Ogata S, Chen A, Maklansky J, Gendler S, Taylor-Papadimitriou J, Xing XP, McKenzie IFC, and Itzkowitz SH (1993). Unmasking of apomucin determinants in gastrointestinal tissues by a novel immunohistochemical technique (abstract). Gastroenterology 104:A410.